Primmune, a wholly-owned subsidiary of TransGenic Inc., launched PAPI’Qss
, a mail-based test service for human papillomavirus.
Primmune news release, February 14, 2017
Primmune Inc. starts assay for human papilloma virus (HPV)
Window to Japan
Window to Japan
Primmune, a wholly-owned subsidiary of TransGenic Inc., launched PAPI’Qss
, a mail-based test service for human papillomavirus.
Primmune news release, February 14, 2017